Culture & Community

Second CEO Conference Call Focuses on Breakthroughs in Cancer and Technology

Marshall Headshot.jpg (1)

On October 10, 2017, nearly 200 American Committee supporters from across the country joined a special conference call with CEO Marshall S. Levin. The second in a series of semi-annual calls focused on “Science at the Leading Edge: Latest Breakthroughs from the Weizmann Institute of Science.” Mr. Levin opened with the news of the Weizmann Institute’s sixth place ranking in the prestigious Nature Index of Innovation, and Weizmann Prof. Michal Schwartz’s distinction as “Lady Globes” Woman of Year for her groundbreaking Alzheimer’s research.

He then discussed two revolutionary therapies, based on Weizmann Institute research, that have saved the lives of patients with prostate cancer and leukemia. This was followed by a glimpse into the world of intelligent machines—and the Weizmann Institute’s efforts to advance the next game-changing breakthroughs in artificial intelligence. Through these and other initiatives, the Institute seeks to improve the quality of life of every person on the planet.

To listen to the recording of the October 10, 2017 call, we invite you to play it here.

Call Archives:

The inaugural February 28, 2017 call focused on Alzheimer’s research and the Bench-to-Bedside Project.

Culture & Community

Second CEO Conference Call Focuses on Breakthroughs in Cancer and Technology

• TAGS: Technology , Community , Leadership , Philanthropy , Cancer

Marshall Headshot.jpg (1)

On October 10, 2017, nearly 200 American Committee supporters from across the country joined a special conference call with CEO Marshall S. Levin. The second in a series of semi-annual calls focused on “Science at the Leading Edge: Latest Breakthroughs from the Weizmann Institute of Science.” Mr. Levin opened with the news of the Weizmann Institute’s sixth place ranking in the prestigious Nature Index of Innovation, and Weizmann Prof. Michal Schwartz’s distinction as “Lady Globes” Woman of Year for her groundbreaking Alzheimer’s research.

He then discussed two revolutionary therapies, based on Weizmann Institute research, that have saved the lives of patients with prostate cancer and leukemia. This was followed by a glimpse into the world of intelligent machines—and the Weizmann Institute’s efforts to advance the next game-changing breakthroughs in artificial intelligence. Through these and other initiatives, the Institute seeks to improve the quality of life of every person on the planet.

To listen to the recording of the October 10, 2017 call, we invite you to play it here.

Call Archives:

The inaugural February 28, 2017 call focused on Alzheimer’s research and the Bench-to-Bedside Project.